z-logo
Premium
Taking AIM2 at regulatory T cells to modulate autoimmune diseases
Author(s) -
Li Xian C.
Publication year - 2021
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.16036
Subject(s) - aim2 , inflammasome , foxp3 , immunology , immune tolerance , immune system , pyroptosis , caspase 1 , inflammation , medicine , autoimmunity , microbiology and biotechnology , cancer research , biology
AIM2 safeguards Treg stability by suppressing the Akt‐mTOR pathway via the protein phosphatase PP2A.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here